I’m with CMC, it says nothing about $30 a month. There is a $11 a month subscription for live US market instead of delayed, hopefully that has market depth and I will subscribe to that
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%